Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Computerized Anesthesia System Identifies Epidural Space

By HospiMedica International staff writers
Posted on 08 Aug 2017
A novel anesthesia system provides objective visual and audible pressure feedback, allowing anesthesiologists to correctly identify the epidural space.

The CompuFlo Epidural Computer Controlled Anesthesia System is intended for use with an epidural needle for real-time verification of needle tip placement in the lumbar epidural space in adult patients. More...
The system uses proprietary dynamic pressure sensing (DPS) technology to verify correct placement; once confirmed, the CompuFlo system is disconnected. The system includes an injection-molded plastic housing that contains the motor-driven piston syringe pumps and internal force sensor, syringe retainer, microprocessor, and a liquid crystal display (LCD) screen display.

A complimentary tray of single-use disposable supplies includes an external in-line fluid pressure sensor, a 20 mL plastic syringe, and a tubing set and adapter that limit use of the disposables; epidural needles and the injectable solution are not supplied in the disposable kit. The CompuFlo system is not intended for medication infusion, must not be used on patients with skin conditions in the lumbar region greater than four cm2, or in patients with prior surgery in the lumbar area that prevents epidural access. The CompuFlo Epidural system is a product of Milestone Scientific (Livingston, NJ, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

“Milestone's painless and precise computerized injection technology platform has the potential to transform drug delivery. Over the coming years, we will be laser-focused on sales and marketing activities, including building our global distribution network,” said Daniel Goldberger, CEO of Milestone Scientific. “Following our recent FDA marketing clearance of the epidural instrument, I look forward to now converting the growing enthusiasm among medical practitioners into broad global commercial adoption.”

“For the first time you precisely can control the rate of administration of a drug, but more importantly you can precisely monitor and control fluid pressure,” said Mark Hochman, MD, director of clinical affairs at Milestone Scientific. “We embarked upon a research project to determine what benefits could be realized from controlling and monitoring both flow-rate and fluid pressure as any drug leaves the needle into a tissue space. That led to the development of a technology that has numerous applications for an unlimited number of different injections.”

Related Links:
Milestone Scientific


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.